| 000 | 01821 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250516181126.0 | ||
| 264 | 0 | _c20140616 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1464-410X | ||
| 024 | 7 |
_a10.1111/bju.12564 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPond, Gregory R | |
| 245 | 0 | 0 |
_aA nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma. _h[electronic resource] |
| 260 |
_bBJU international _cMay 2014 |
||
| 300 |
_aE137-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNomograms |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aUrologic Neoplasms _xdrug therapy |
| 700 | 1 | _aAgarwal, Neeraj | |
| 700 | 1 | _aBellmunt, Joaquim | |
| 700 | 1 | _aChoueiri, Toni K | |
| 700 | 1 | _aQu, Angela | |
| 700 | 1 | _aFougeray, Ronan | |
| 700 | 1 | _aVaughn, David | |
| 700 | 1 | _aJames, Nicholas D | |
| 700 | 1 | _aSalhi, Yacine | |
| 700 | 1 | _aAlbers, Peter | |
| 700 | 1 | _aNiegisch, Günter | |
| 700 | 1 | _aGalsky, Matthew D | |
| 700 | 1 | _aWong, Yu-Ning | |
| 700 | 1 | _aKo, Yoo-Joung | |
| 700 | 1 | _aStadler, Walter M | |
| 700 | 1 | _aO'Donnell, Peter H | |
| 700 | 1 | _aSridhar, Srikala S | |
| 700 | 1 | _aVogelzang, Nicholas J | |
| 700 | 1 | _aNecchi, Andrea | |
| 700 | 1 | _aDi Lorenzo, Giuseppe | |
| 700 | 1 | _aSternberg, Cora N | |
| 700 | 1 | _aMehta, Amitkumar | |
| 700 | 1 | _aSonpavde, Guru | |
| 773 | 0 |
_tBJU international _gvol. 113 _gno. 5b _gp. E137-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bju.12564 _zAvailable from publisher's website |
| 999 |
_c23255027 _d23255027 |
||